Entering text into the input field will update the search result below
Create free account
Search for Symbols, analysts, keywords
Log in
TNXP
Tonix Pharmaceuticals Holding Corp.
Latest News
Follow
$0.18
0.01 (+7.25%)
4:00 PM 05/03/24
NASDAQ |
$USD |
Post-Market:
$0.19
+0.00 (+1.36%)
7:56 PM
Summary
Ratings
Financials
Earnings
Dividends
Valuation
Growth
Profitability
Momentum
Peers
Options
Charting
All
Analysis
Comments
News
SEC Filings
Press Releases
Related Analysis
TNXP News
Show Full Stories
Show Full Stories
This feature available only for pro users
Type:
All Types
Date Range:
Select Date
Tonix Pharmaceuticals GAAP EPS of -$0.86, revenue of $3.78M
Tonix picks CMOs for potential launch of fibromyalgia drug
Tonix stock climbs 9% after FDA approves PTSD study
Tonix Pharmaceuticals announces $144M of registered direct offering
Tonix stock climbs as PWS therapy cleared for clinical studies
Tonix Pharmaceuticals GAAP EPS of -$1.83, revenue of $4M
Tonix pulls plug on drug TNX-601 ER for depression, stock plunges 35%
Tonix Pharmaceuticals slumps 33%, prices $4.5M equity
Tonix Pharmaceuticals announces proposed public offering
Tonix stock slides 10% on failed Phase 2 study for Long COVID drug
Tonix Pharmaceuticals GAAP EPS of -$2.68 misses by $0.66
Tonix Pharmaceuticals stock sinks on pricing $7M public offering
Tonix Pharmaceuticals announces proposed public offering
Tonix Pharma to acquire two FDA-approved migraine therapies
Monkeypox is no longer a global health emergency – WHO
Tonix Pharma falls 30% after announcing another reverse stock split
Tonix Pharmaceuticals GAAP EPS of -$0.52
Tonix Pharmas' TNX-1500 cleared for IND to prevent organ rejection in kidney transplant patients
Tonix puts COVID programs on the back burner in portfolio overhaul
Catalyst watch: Tesla deliveries, Walmart event and jobs report headline big week
Tonix starts enrollment in mid-stage study of depression drug TNX-601 ER
Tonix Pharmaceuticals GAAP EPS of -$0.56 beats by $0.30
Tonix Pharma rises on positive data from preclinical study of colorectal cancer therapy
Tonix buys preclinical antiviral portfolio from Healion Bio
Tonix Pharma collaborates to study TNX-1500 to prevent rejection in heart xenograft transplantation
Tonix Pharmaceuticals regains compliance with Nasdaq minimum bid price requirement
Tonix stock surges 20% on licensing deal for antibodies for COVID-19
Monkeypox plays in the red as U.S. to end public health emergency
World Health Organization renames monkeypox as mpox
Tonix Pharmaceuticals GAAP EPS of -$0.69 beats by $0.33
Monkeypox remains a global health emergency – WHO
Tonix Pharmaceuticals rises on pricing $15M preferred stock offering
Tonix stock rises on FDA nod to start trial of TNX-601 for depression
Texas reports first U.S. death linked to monkeypox
Monkeypox cases drop 21% globally as outbreak eases in Europe – WHO
U.S. monkeypox cases exceed 10,000
Tonix Pharmaceuticals GAAP EPS of -$1.22 beats by $0.23
U.S. declares monkeypox a public health emergency
Biden names top officials to lead monkeypox response as more states cite emergencies
Tonix gets federal grant to develop TNX-1300 for treating cocaine intoxication
1
2
3
4
5
Next
People Also Follow
Similar to TNXP
ETFs Holding TNXP
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.